Asthma Drugs To Display More Prominent Psychiatric Warning
Featured on: Pharma Times
Publication date: Jun 15, 2009
Publication date: Jun 15, 2009
Reports of behavioral and mood changes in patients using asthma therapies belonging to the leukotriene inhibitors class of drugs have lead to a call for stronger precautions in the drugs' labeling. U.S. regulators are calling for the warnings after patients have reported a range of neuropsychiatric side effects.
Read Full Article
Read Full Article
More Allergies Asthma Articles
Nowhere To Hide. Allergy Season Is In Full SwingAccuracy Of Allergy Tests Varies
The Myths About Asthma, And How Country Living Can Be As Bad For Sufferers As The City
Asthma Patients Need To Be Cautious And Knowledgeable Of Swine Flu
Family Opens Daycare For Children With Allergies
Asthma Self-management Programs Improve Drug Adherence, Disease Control
Ear And Sinus Allergies
Asthma Action Plan For Adults
Local Study Finds Factors That Lead To Better Asthma Control
Gluten Allergy Can Be Serious










